Mitochondrial Health Virtual Shadowing Session 88 – "Innovation in Medicine" February 8, 2022Aloha source
Mitochondrial Health Reacting to Milos Sarcev’s DNP Story | @Leo and Longevity November 22, 2022Tony Huge Censored
Mitochondrial Health mitochondria structure and function diagram mitochondria c October 9, 2022MLT ikram
4:25 – Physical Innovation Introduction 6:59 – Goals & Objectives8:01 – Physician Scope in Healthcare Innovation 18:00 – Intellectual Property 23:35 – Case Study 1 (memory loss)26:20 – Synapses27:55 – Amyloid beta28:45 – Dynamic Related Proteins31:00 – Synaptex pharmaceuticals 32:20 – Team33:15 – Company Overview34:50 – Problem & Market35:45 – Solution 37:25 – Mitochondria37:40 – Urolithin analogs – Our Discoveries37:46 – Publications40:10 – Key Partners & Traction40:53 – Next Steps41:09 – Switching Gears – Intellectual Property 43:30 – Healthcare is expensive52:07 – Q&A1:12:01 – Patent System 1:18:00 – Invention 1:24:35 – UTDesign Capstone1:27:45 – Patent Application 1:31:40 – Patent Prosecution 1:34:45 – Case Study 2 (Hemarthrosis)1:37:35 – Pennsylvania Patient Safety Authority, March 20161:38:50 – Risks of Prolonged Venous Stasis 1:40:20 – Current Tourniquet Design 1:41:00 – Required Tension for Phlebotomy 1:43:30 – Time-To-Failure1:46:14 – Next Steps and Trials 1:46:50 – Case Study 31:49:50 – Osteoporosis 1:53:40 – Device Distinction 1:56:22 – Regulatory Considerations1:57:50 – Q&A Reply
4:25 – Physical Innovation Introduction
6:59 – Goals & Objectives
8:01 – Physician Scope in Healthcare Innovation
18:00 – Intellectual Property
23:35 – Case Study 1 (memory loss)
26:20 – Synapses
27:55 – Amyloid beta
28:45 – Dynamic Related Proteins
31:00 – Synaptex pharmaceuticals
32:20 – Team
33:15 – Company Overview
34:50 – Problem & Market
35:45 – Solution
37:25 – Mitochondria
37:40 – Urolithin analogs – Our Discoveries
37:46 – Publications
40:10 – Key Partners & Traction
40:53 – Next Steps
41:09 – Switching Gears – Intellectual Property
43:30 – Healthcare is expensive
52:07 – Q&A
1:12:01 – Patent System
1:18:00 – Invention
1:24:35 – UTDesign Capstone
1:27:45 – Patent Application
1:31:40 – Patent Prosecution
1:34:45 – Case Study 2 (Hemarthrosis)
1:37:35 – Pennsylvania Patient Safety Authority, March 2016
1:38:50 – Risks of Prolonged Venous Stasis
1:40:20 – Current Tourniquet Design
1:41:00 – Required Tension for Phlebotomy
1:43:30 – Time-To-Failure
1:46:14 – Next Steps and Trials
1:46:50 – Case Study 3
1:49:50 – Osteoporosis
1:53:40 – Device Distinction
1:56:22 – Regulatory Considerations
1:57:50 – Q&A